Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Amgen, 4% 13sep2029, GBP
XS0829324457

Download
Copy issue information to clipboard
Copy issue information to clipboard
✓
Copy

Senior Unsecured

Issue
Issuer
  • M
    -
    ****
  • S&P
    -
    ****
  • F
    -
    ****
*in foreign currency
Status
Outstanding
Amount
700,000,000 GBP
Placement
***
Early redemption
*** (-)
Country of risk
USA
Current coupon
***%
Price
***%
Yield / Duration
-
Calculator What is a calculator?
Corporate Actions Issuer news
Add issue to Watchlist
Choose all Reset all
{{ watchlistErrorMsg }}
Save Collapse
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
Calculator
What is a calculator?
Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Files

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
from
to
ADD-IN
Cbonds add-in API
bond data api
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Request additional prices

Issue information

Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel ...
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
Show more Hide
  • Borrower
    Go to the issuer page
    Amgen
  • Full issuer name
    Amgen, Inc.
  • Sector
    corporate
  • Industry
    Healthсare
Volume
  • Amount
    700,000,000 GBP
  • Outstanding face value amount
    700,000,000 GBP
  • USD equivalent
    953,260,000 USD
Nominal
  • Minimum Settlement Amount
    100,000 GBP
  • Outstanding face value
    *** GBP
  • Par amount, integral multiple
    *** GBP
  • Nominal
    1,000 GBP

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** GBP
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms
    ***

Additional information

***

Latest issues

Show all

News

13/11/2020 Fitch Ratings affirms Amgen at "BBB+" (LT Int. Scale (foreign curr.) credit rating); outlook stable
02/09/2020 Fitch Ratings affirms Amgen at "BBB+" (LT Int. Scale (foreign curr.) credit rating); outlook stable
06/05/2020 New bond issue: Amgen issued international bonds (US031162CW82) with a 2.3% coupon for USD 1,250.0m maturing in 2031
19/02/2020 New bond issue: Amgen issued international bonds (US031162CS70) with a 3.375% coupon for USD 1,250.0m maturing in 2050
19/02/2020 New bond issue: Amgen issued international bonds (US031162CR97) with a 3.15% coupon for USD 1,250.0m maturing in 2040
19/02/2020 New bond issue: Amgen issued international bonds (US031162CU27) with a 2.45% coupon for USD 1,250.0m maturing in 2030
19/02/2020 New bond issue: Amgen issued international bonds (US031162CT53) with a 2.2% coupon for USD 750.0m maturing in 2027
19/02/2020 New bond issue: Amgen issued international bonds (US031162CV00) with a 1.9% coupon for USD 500.0m maturing in 2025
22/11/2019 S&P Global Ratings downgrades Local Currency LT credit rating of Amgen to "A-"; outlook stable
22/11/2019 S&P Global Ratings downgrades Foreign Currency LT credit rating of Amgen to "A-"; outlook stable
All organization news

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN
    XS0829324457
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    082932445
  • CFI
    DBFNBR
  • FIGI
    BBG003CNT2M9
  • WKN
    A1G9G8
  • SEDOL
    B8MYVZ7
  • Ticker
    AMGN 4 09/13/29
  • Type of security by CBR
    ***
Show more Hide

Ratings



Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Floating rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

***

IFRS/US GAAP reports

2020
I q eng
II q eng
III q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Holders

Copyright (c) 2004-2021 CbondS